Oscar Health OSCR
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 84th percentile, 5-year average -40.6x
#1069 of 2994 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 81st percentile, 5-year average 2.8x
#4231 of 5331 stocks by PB (1 = cheapest)
Above its usual level · 67th percentile, 5-year average 0.5x
#1082 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 4.34 | – | 2.82 | 81% (pricier than usual) | #4231 of 5331 (1 = cheapest) |
| PE | 13.80 | 10.70 | -40.58 | 84% (pricier than usual) | #1069 of 2994 (1 = cheapest) |
| PS | 0.55 | 0.45 | 0.50 | 67% (pricier than usual) | #1082 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on OSCR.
Sign in to join the discussion.